DiaCarta, Inc.

DiaCarta, Inc.

DiaCarta, Inc.

Improving patient care through novel precision molecular diagnostics: CE/IVD marked tests are available for detection of KRAS, NRAS, EGFR, BRAF, PIK3CA, JAK2 .
Type
B2b
Founded
2010
Raised
$53M
Follow us
Alexa global traffic share